Advanced cell therapies are among the most expensive medical treatments globally, with list prices for breakthrough commercial CAR-T treatments often ranging between $370,000 to over $500,000 USD for a single course of therapy. These high costs are driven by complex, highly personalized manufacturing processes, specialized facility requirements, intensive patient hospital care, and extensive research and development expenditures amortized across small patient populations.